Approaches to management of rhabdomyolysis as the adverse effect of drug interaction between atorvastatin and sacubitril/valsartan: a case report

BACKGROUND: Atorvastatin and sacubitril/valsartan (Entresto™) have been cornerstones in managing patients with coronary artery disease and heart failure (HF). We report a case of life-threatening rhabdomyolysis associated with the co-administration of atorvastatin and sacubitril/valsartan. CASE SUMM...

Descripción completa

Detalles Bibliográficos
Autores principales: Siew, Kelvin Shenq Woei, Abdul Hafidz, Muhammad Imran, Mohd Zaidan, Fatimah Zahrah Binti, Hadi, Mohd Firdaus bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8895310/
https://www.ncbi.nlm.nih.gov/pubmed/35261962
http://dx.doi.org/10.1093/ehjcr/ytac091

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8895310/
https://www.ncbi.nlm.nih.gov/pubmed/35261962
http://dx.doi.org/10.1093/ehjcr/ytac091

Ejemplares similares